Top

The European Journal of Health Economics

Open Access 28-09-2024 | Leukemia | Original Paper

Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain

Authors: Josep Darbà, Meritxell Ascanio, Ainoa Agüera

Published in: The European Journal of Health Economics

Abstract

Introduction

Cancer mortality is one of the dominant causes of productivity loss; and within all cancer sites, blood cancer is the fourth most common cause of death in Spain. Thus, its impacts in work productivity are a major concern and represent a high social impact. The aim of this study was to evaluate the productivity losses resulting from of premature deaths due to leukaemia in Spain.

Methods

The productivity costs stemming from premature mortality due to leukaemia were estimated using the human capital method. Information pertaining to mortality rates, typical incomes, and joblessness figures was gathered throughout a decade-long period spanning from 2012 to 2021.

Results

Leukaemia caused 40% of haematological malignancies losses. It represented a 3.39% of all cancer-related deaths. In addition, it was responsible for 7,851 years of potential productive life lost (YPLPLL) in 2021, and productivity losses of €4,206.52 million over the 10-year period. All these numbers are relevant for Spain as will help on a more efficient distribution of resource.

Conclusions

These productivity losses obtained, highlight the burden of leukaemia on the Spanish population, providing novel data on the number of deaths, trends and productivity losses for this type of cancer. This evaluation offers fresh insights that can aid policymakers in efficiently distributing resources, thereby lessening the economic burden it imposes on individuals of working age.

Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D.M., Piñeros, M., Znaor, A., Bray, F.: Cancer statistics for the year 2020: An overview. Int. J. Cancer. (2021). https://doi.org/10.1002/ijc.33588CrossRefPubMed

Ortega-Ortega, M., Hanly, P., Pearce, A., et al.: Projected impact on Labour Productivity costs of Cancer-related premature mortality in Europe 2018–2040. Appl. Health Econ. Health Policy. (2023). https://doi.org/10.1007/s40258-023-00824-6CrossRefPubMedPubMedCentral

Hanly, P., Soerjomataram, I., Sharp, L.: Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer-related mortality in Europe. Int. J. Cancer. (2015). https://doi.org/10.1002/ijc.29105CrossRefPubMed

Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., et al.: Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur. J. Cancer. (2018). https://doi.org/10.1016/j.ejca.2018.07.005CrossRefPubMedPubMedCentral

World Health Organization (WHO): Cancer EURO. (2024). https://www.who.int/europe/health-topics/cancer#tab=tab_1 Accessed

Krol, M., Brouwer, W.: How to estimate productivity costs in economic evaluations. Pharmacoeconomics. (2014). https://doi.org/10.1007/s40273-014-0132-3CrossRefPubMed

Zhang, W., Bansback, N., Anis, A.H.: Measuring and valuing productivity loss due to poor health: A critical review. Soc. Sci. Med. (2011). https://doi.org/10.1016/j.socscimed.2010.10.026CrossRefPubMedPubMedCentral

van den Hout, W.B.: The value of productivity: Human-capital versus friction-cost method. Ann. Rheum. Dis. (2010). https://doi.org/10.1136/ard.2009.117150CrossRefPubMed

Kigozi, J., Jowett, S., Lewis, M., Barton, P., Coast, J.: Estimating productivity costs using the friction cost approach in practice: A systematic review. Eur. J. Health Econ. (2016). https://doi.org/10.1007/s10198-014-0652-yCrossRefPubMed

10.

Yabroff, K.R., Bradley, C.J., Mariotto, A.B., Brown, M.L., Feuer, E.J.: Estimates and projections of value of life lost from cancer deaths in the United States. J. Natl. Cancer Inst. (2008). https://doi.org/10.1093/jnci/djn383CrossRefPubMedPubMedCentral

11.

Hofmarcher, T., Lindgren, P., Wilking, N., Jönsson, B.: The cost of cancer in Europe 2018. Eur. J. Cancer. (2020). https://doi.org/10.1016/j.ejca.2020.01.011CrossRefPubMed

12.

Ortega-Ortega, M., Hanly, P., Pearce, A., Soerjomataram, I., Sharp, L.: Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. Int. J. Cancer. (2022). https://doi.org/10.1002/ijc.33826CrossRefPubMed

13.

Parker, C., Liew, D., Ademi, Z., Owen, A.J., Ayton, D., Wei, A., Zomer, E.: Estimating the Productivity Impact of Acute myeloid leukemia in Australia between 2020 and 2029, using a Novel Work Utility measure: The Productivity-Adjusted Life Year (PALY). JCO Oncol. Pract. (2021). https://doi.org/10.1200/OP.20.00904CrossRefPubMed

14.

Juliusson, G., Abrahamsson, J., Lazarevic, V., Antunovic, P., Derolf, Å., Garelius, H., et al.: Swedish AML Group and the Swedish Childhood Leukemia Group. Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden. Leukemia. (2017). https://doi.org/10.1038/leu.2016.312CrossRefPubMed

15.

Hochhaus, A., Saussele, S., Rosti, G., Mahon, F.X., Janssen, J.J.W.M., Hjorth-Hansen, H., Richter, J., Buske, C., ESMO Guidelines Committee: Chronic myeloid leukaemia: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. (2017). https://doi.org/10.1093/annonc/mdx219CrossRefPubMed

16.

Heuser, M., Ofran, Y., Boissel, N., Brunet Mauri, S., Craddock, C., Janssen, J., Wierzbowska, A., Buske, C., ESMO Guidelines Committee: Acute myeloid leukaemia in adult patients: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. (2020). https://doi.org/10.1016/j.annonc.2020.02.018CrossRefPubMed

17.

Carter, H.E., Schofield, D.J., Shrestha, R.: The Productivity costs of premature mortality due to Cancer in Australia: Evidence from a Microsimulation Model. PLoS One. (2016). https://doi.org/10.1371/journal.pone.0167521CrossRefPubMedPubMedCentral

18.

Bradley, C.J., Yabroff, K.R., Dahman, B., Feuer, E.J., Mariotto, A., Brown, M.L.: Productivity costs of cancer mortality in the United States: 2000–2020. J. Natl. Cancer Inst. (2008). https://doi.org/10.1093/jnci/djn384CrossRefPubMedPubMedCentral

19.

Oliva-Moreno, J.: Loss of labour productivity caused by disease and health problems: What is the magnitude of its effect on Spain’s economy? Eur. J. Health Econ. (2012). https://doi.org/10.1007/s10198-011-0344-9CrossRefPubMed

20.

Peña-Longobardo, L.M., Aranda-Reneo, I., Oliva-Moreno, J., Vall-Castello, J.: Pérdidas laborales ocasionadas por muertes prematuras en España: Un análisis para El Periodo 2005–2009. Rev. Esp. Salud Pública. (2015). https://doi.org/10.4321/s1135-57272015000100005CrossRefPubMed

21.

Spanish Statistical Office: Death statistics according to cause of death. [Instituto Nacional de Estadística (INE). Estadística de defunciones según la causa de muerte]. http://www.ine.es/dyngs/INEbase/es/operacion.htm?c=Estadistica_C&cid=1254736176780&menu=resultados&idp=1254735573175 Accessed June 2024

22.

Spanish Statistical Office: Labour Force Survey [Instituto Nacional de Estadística (INE). Encuesta de población activa.] http://www.ine.es/dyngs/INEbase/es/categoria.htm?c=Estadistica_P&cid=1254735976594 Accessed June 2024

23.

Spanish Statistical Office: Wage structure survey [Instituto Nacional de Estadística (INE). Encuesta de estructura salarial]. http://www.ine.es/dyngs/INEbase/es/categoria.htm?c=Estadistica_P&cid=1254735976594 Accessed June 2024

24.

Peña-Longobardo, L.M., Oliva-Moreno, J., Fernández-Rodriguez, C.: The effect of hepatitis C—associated premature deaths on labour productivity losses in Spain: A ten-year analysis. Eur. J. Health Econ. (2023). https://doi.org/10.1007/s10198-022-01540-zCrossRefPubMed

25.

Social Welfare: Workers’ benefits/pensions [Seguridad Social. Prestaciones/Pensiones de trabajadores]. (2024). https://www.seg-social.es/wps/portal/wss/internet/Trabajadores/PrestacionesPensionesTrabajadores/10963/28393/28396/28472#6156 Accessed

26.

Scarfò, L., Ferreri, A.J.M., Ghia, P.: Chronic lymphocytic leukaemia. Crit. Rev. Oncol. Hematol. (2016). https://doi.org/10.1016/j.critrevonc.2016.06.003CrossRefPubMed

27.

Döhner, H., Wei, A.H., Appelbaum, F.R., Craddock, C., DiNardo, C.D., Dombret, H., et al.: Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. (2022). https://doi.org/10.1182/blood.2022016867CrossRefPubMedPubMedCentral

28.

De-Morgan, A., Meggendorfer, M., Haferlach, C., Shlush, L.: Male predominance in AML is associated with specific preleukemic mutations. Leukemia. (2021). https://doi.org/10.1038/s41375-020-0935-5CrossRefPubMed

29.

Rissanen, I., Ala-Mursula, L., Nerg, I., Korhonen, M.: Adjusted productivity costs of stroke by human capital and friction cost methods: A Northern Finland Birth Cohort 1966 study. Eur. J. Health Econ. (2021). https://doi.org/10.1007/s10198-021-01271-7CrossRefPubMedPubMedCentral

30.

Bradley, C.J., Oberst, K., Schenk, M.: Absenteeism from work: The experience of employed breast and prostate cancer patients in the months following diagnosis. Psychooncology. (2006). https://doi.org/10.1002/pon.1016CrossRefPubMed

31.

Jo, C.: Cost-of-illness studies: Concepts, scopes, and methods. Clin. Mol. Hepatol. (2014). https://doi.org/10.3350/cmh.2014.20.4.327CrossRefPubMedPubMedCentral

32.

Krol, M., Brouwer, W., Rutten, F.: Productivity costs in economic evaluations: Past, present, future. Pharmacoeconomics. (2013). https://doi.org/10.1007/s40273-013-0056-3

33.

Pike, J., Grosse, S.D.: Friction cost estimates of Productivity costs in cost-of-illness studies in comparison with human capital estimates: A review. Appl. Health Econ. Health Policy. (2018). https://doi.org/10.1007/s40258-018-0416-4CrossRefPubMedPubMedCentral

34.

Sittimart, M., Rattanavipapong, W., Mirelman, A.J., Hung, T.M., Dabak, S., Downey, L.: An overview of the perspectives used in health economic evaluations. Cost Eff. Resour. Alloc. (2024). https://doi.org/10.1186/s12962-024-00552-1CrossRefPubMedPubMedCentral

Title: Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain
Authors: Josep Darbà
Meritxell Ascanio
Ainoa Agüera
Publication date: 28-09-2024
Publisher: Springer Berlin Heidelberg
Keyword: Leukemia
Published in: The European Journal of Health Economics
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI: https://doi.org/10.1007/s10198-024-01727-6

Keynote webinar | Spotlight on adolescent vaping

Springer Medicine

Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain

Abstract

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on adolescent vaping

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content